BIO-RAD LABORATORIES-A (BIO) Stock Price, Forecast & Analysis
USA - NYSE:BIO - US0905722072 - Common Stock
BIO Key Statistics, Chart & Performance
The current stock price of BIO is 309.22 USD. In the past month the price increased by 2.63%. In the past year, price decreased by -17.25%.
BIO Latest News, Press Relases and Analysis
BIO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.81 | 218.31B | ||
| DHR | DANAHER CORP | 27.45 | 151.54B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 161.79 | 49.09B | ||
| A | AGILENT TECHNOLOGIES INC | 27 | 41.71B | ||
| IQV | IQVIA HOLDINGS INC | 18.41 | 36.40B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 34.52 | 29.75B | ||
| WAT | WATERS CORP | 29.76 | 22.50B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 39.02 | 19.84B | ||
| ILMN | ILLUMINA INC | 28.04 | 18.79B | ||
| MEDP | MEDPACE HOLDINGS INC | 42.18 | 16.95B | ||
| TEM | TEMPUS AI INC | N/A | 12.63B | ||
| RVTY | REVVITY INC | 19.32 | 10.74B |
Related stock screener links
About BIO
Company Profile
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company is headquartered in Hercules, California and currently employs 7,700 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Company Info
BIO-RAD LABORATORIES-A
1000 Alfred Nobel Dr
Hercules CALIFORNIA 94547 US
CEO: Norman Schwartz
Employees: 7700
Phone: 15107247000
BIO-RAD LABORATORIES-A / BIO FAQ
What does BIO do?
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company is headquartered in Hercules, California and currently employs 7,700 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
What is the stock price of BIO-RAD LABORATORIES-A today?
The current stock price of BIO is 309.22 USD. The price increased by 1.2% in the last trading session.
Does BIO stock pay dividends?
BIO does not pay a dividend.
What is the ChartMill technical and fundamental rating of BIO stock?
BIO has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for BIO stock?
10 analysts have analysed BIO and the average price target is 317.22 USD. This implies a price increase of 2.59% is expected in the next year compared to the current price of 309.22.
How is the valuation of BIO-RAD LABORATORIES-A (BIO) based on its PE ratio?
The PE ratio for BIO-RAD LABORATORIES-A (BIO) is 29.99. This is based on the reported non-GAAP earnings per share of 10.31 and the current share price of 309.22 USD.
Would investing in BIO-RAD LABORATORIES-A be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BIO.
BIO Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to BIO. When comparing the yearly performance of all stocks, BIO is a bad performer in the overall market: 61.02% of all stocks are doing better.
BIO Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to BIO. While BIO has a great health rating, its profitability is only average at the moment.
BIO Financial Highlights
Over the last trailing twelve months BIO reported a non-GAAP Earnings per Share(EPS) of 10.31. The EPS decreased by -1.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.97% | ||
| ROE | -10.03% | ||
| Debt/Equity | 0.18 |
BIO Forecast & Estimates
10 analysts have analysed BIO and the average price target is 317.22 USD. This implies a price increase of 2.59% is expected in the next year compared to the current price of 309.22.
For the next year, analysts expect an EPS growth of -1.6% and a revenue growth 0.42% for BIO